KZA Media Thread, page-1275

First 1275 Last

Share
Profile

Follow
Rich&Poor

1,144 Posts.

819

24/01/21

11:27

Post #: 50405603
Share

Originally posted by Firesale: ↑

https://unauthorised investment advice/health/clinical-trial-tracker-the-tests-asx-healthcare-companies-have-upcoming-in-2021/

Given its size, Kazia Therapeutics(ASX:KZA), a $160 million Sydney company developing treatments for brain and ovarian cancer, was a standout in our tracker with the amount of research underway.
Kazia chief executive and executive director Dr James Garner told*that the Sydney company had eight different clincial trials in progress – seven in collaboration with world-renown organisations including the Dana-Farber Cancer Institute in Boston and the Memorial Sloan Kettering Cancer Center in New York City.
“We wanted to put into place a very international-grade research program,” to add value to Kazia’s assets while avoiding the trap some Australian biopharmaceutical companies run into of running from financing round to financing round, Dr Garner said.
Partnerships give Kazia the best “bang for the buck” even if the company loses some control over the process, he said.
Only one of Kazia’s clinical trials is explicitly designed as a “pivotal” study, meaning one that could be used to apply for a regulatory approval. But given that some of the research is into very rare pediatric brain cancers, regulators might accept the results of one of the smaller studies to progress a drug to market, Dr Garner said.

Expand

Firesale 3 good posts. I did read the S-t-o-c-k-h-e-a-d article on - health/clinical-trial-tracker-the-tests-asx-healthcare-companies-have-upcoming-in-2021/ on Friday, had the article ready to post, then deleted it because of the censorship previously received from Hot Copper. You cannot link unauthorized organizations.

Well done Dr James Garner on the article.

Regards.

KZA Price at posting: $1.40 Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

ARN

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

There are more pages in this discussion • 792 more messages in this thread...

First 1275 Last

Add KZA (ASX) to my watchlist

KZA Media Thread, page-1275

Top Stories

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News